Masimo | MASI - Equity Capital And Reserves


Masimo reported $788.9M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
Align Technology USD 4.15B 100.27M Mar/2026
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 450.47M 2.24M Mar/2026
AtriCure USD 491.69M 242K Mar/2026
Avanos Medical USD 782.1M 3.9M Mar/2026
Baxter International USD 6.04B 86M Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Boston Scientific USD 25.86B 1.63B Mar/2026
Dexcom USD 2.96B 210.9M Mar/2026
Edwards Lifesciences USD 10.33B 10.1M Mar/2026
General Electric Aerospace USD 18.06B 841M Mar/2026
Globus Medical USD 4.73B 159.06M Mar/2026
Haemonetics USD 796.32M 115.13M Mar/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.3B 212.6M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
Intuitive Surgical USD 17.47B 349.5M Mar/2026
Masimo USD 788.9M 67.7M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Orthofix International USD 435.19M 14.85M Mar/2026
Owens Minor USD -464.76M 3.79M Mar/2026
ResMed USD 6.49B 171.03M Mar/2026
Steris USD 7.18B 29.1M Mar/2026
Stryker USD 22.42B 635M Dec/2025
Tandem Diabetes Care USD 132.4M 22.77M Mar/2026
Teleflex USD 3.08B 40.33M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026